Log in to search using one of your social media accounts:


FOXO in Neural Cells and Diseases of the Nervous System.

FOXO in Neural Cells and Diseases of the Nervous System. Curr Top Dev Biol. 2018;127:105-118 Authors: Santo EE, Paik J Abstract The evolutionarily conserved FOXO family of transcription factors has emerged as a significant arbiter of neural cell fate and function in mammals. From the neural stem cell (NSC) state through mature neurons under both physiological and pathological conditions, they have been found to modulate neural cell survival, stress responses, lineage commitment, and neuronal signaling. Lineage-specific FOXO knockout mice have provided an invaluable tool for the dissection of FOXO biology in the nervous system. Within the NSC compartments of the brain, FOXOs are required for the maintenance of NSC quiescence and for the clearance of reactive oxygen species. Within mature neurons, FOXO transcriptional activity is essential for the prevention of age-dependent axonal degeneration. Acutely, FOXO3 has been found to cause axonal degeneration upon withdrawal of neurotrophic factors. In more active neural signaling, FOXO6 promotes increased dendritic spine density of hippocampal neurons and is required for the consolidation of memories. In addition to the central nervous system (CNS), FOXOs also influence the functionality of the peripheral nervous system (PNS). FOXO1 knockout within the PNS results in a reduction of sympathetic tone and decreased levels of brain-derived norepinephrine and lower energy expenditure. FOXO3 knockout mice have impair...
Source: Current Topics in Developmental Biology - Category: Biology Authors: Tags: Curr Top Dev Biol Source Type: research

Related Links:

KEEPING fit in older age helps stave off Alzheimer ’s disease, according to research. Scientists have discovered that bursts of exercise, such as a bike ride or a brisk walk, boost “white matter” tissue found deep within the brain.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Scientists create hybrid embryos with stem cells from both species
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
Authors: Zauszniewski JA, Lekhak N, Musil CM Abstract Currently, 15 million informal caregivers, most of whom are women, provide care for older adults with dementia (Alzheimer's Disease Association, 2016). Caregiving for these individuals often creates distress and may adversely affect female caregivers' psychosocial and spiritual well-being. Approximately 35% of dementia caregivers complain of health deterioration after initiating caregiving responsibilities as compared to 19% of caregivers of older adults who do not have dementia (Alzheimer's Disease Association, 2016). Persons with dementia exhibit symptoms...
Source: Issues in Mental Health Nursing - Category: Nursing Tags: Issues Ment Health Nurs Source Type: research
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Authors: Gale RP, Hochhaus A Abstract Chronic myeloid leukemia (CML) can be cured using tyrosine kinase-inhibitors (TKIs) when cure is defined as achieving a life-expectancy similar or even better than sex- and age-matched persons without CML. Most deaths in persons with CML are now from non-leukemia-related causes including heart disease, diabetes other cancers and stroke. Contrary to expectation, 40-50 percent of persons with CML treated for a few years with TKIs and who achieve a deep molecular response can stop TKI-therapy without leukemia recurrence for several years, some possibly indefinitely. Consequently, ...
Source: Expert Review of Hematology - Category: Hematology Tags: Expert Rev Hematol Source Type: research
Authors: Brandl C, Weber BHF Abstract Today, the search for therapeutic options to treat retinal degeneration often relies on an in-depth understanding of the underlying pathological events. Alternatively, it is conceivable to search, in an undirected screening approach, for chemical compounds affecting disease outcome. For both approaches, there is an urgent need for in vitro and, ideally, in vivo disease models that adequately reflect the site of pathology. Currently available animal models possess limitations as they often develop only defined aspects of disease. Primary cell cultures, derived from the posterior...
Source: Klinische Monatsblatter fur Augenheilkunde - Category: Opthalmology Tags: Klin Monbl Augenheilkd Source Type: research
From the FDA:Early Alzheimer ’s Disease: Developing Drugs for Treatment Guidance for Industry (Draft Guidance)February 2018Early Alzheimer ’s Disease: Developing Drugs for Treatment Guidance for Industry (Draft Guidance)
Source: BrainBlog - Category: Neurology Source Type: blogs
CONCLUSIONS: Memantine is a viable treatment option for patients with AD presenting not only with cognitive impairment, but also with a broader range of symptoms, including the behavioral and psychological symptoms of dementia. PMID: 29448852 [PubMed - as supplied by publisher]
Source: Expert Opinion on Pharmacotherapy - Category: Drugs & Pharmacology Tags: Expert Opin Pharmacother Source Type: research
Source: NPR Health and Science - Category: Consumer Health News Authors: Source Type: news
The pioneering geneticist on why he wants us to earn money by sharing our genomic data, his plans to resurrect the woolly mammoth and how narcolepsy helps him generate ideas• How can I make money from my DNA?A new genetic testing company calledNebula Genomics wants to help people profit from their own genomes. The Observer talks to Harvard University DNA sequencing pioneer George Church about his latest venture, what ’s cooking in his lab and how falling asleep on the job can sometimes be a godsend.What is the value of getting your genome sequenced? Why do it?One very compelling argument that I think justifies a...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Genetics Science Biology Medical research Stem cells Source Type: news
More News: ALS | Alzheimer's | Biology | Brain | Expenditures | Huntington's Disease | Neurology | Parkinson's Disease | Reflex Sympathetic Dystrophy | Stem Cell Therapy | Stem Cells | Study